What additional counseling should be provided to patients on INH therapy?

For patients on INH (Isoniazid) therapy, it is crucial to provide counseling on the signs of liver damage and the importance of medication adherence. INH is known to have hepatotoxic effects, particularly in individuals with pre-existing liver conditions or those who consume alcohol. Patients should be informed about symptoms such as jaundice (yellowing of the skin and eyes), abdominal pain, dark urine, and unusual fatigue, which may indicate liver dysfunction.

Additionally, emphasizing medication adherence is vital, as INH is most effective when taken consistently as prescribed. Non-adherence can lead to treatment failure, development of drug-resistant tuberculosis, and increased risk of transmission. This education ensures that patients understand the importance of completing their treatment course and monitoring any potential side effects related to liver health. Overall, this focused counseling serves to promote patient safety and the effectiveness of the tuberculosis treatment regimen.